Prognostic value of high-sensitive troponin T in patients with severe aortic stenosis undergoing valve replacement

Alaa Salama1, Ghada Ibrahim1, Mohammad Fikry1

  • 1Cardiology Department, Zagazig University, Zagazig, Egypt.

Insights

High-sensitive troponin T (hs-TnT) predicts poor prognosis in severe aortic stenosis patients post-aortic valve replacement. hs-TnT and global longitudinal strain (GLS) are key predictors of major adverse cardiovascular events.

Area of Science:

  • Cardiology
  • Biomarkers
  • Echocardiography

Background:

  • Aortic stenosis (AS) is a significant cause of mortality.
  • Severe AS with preserved left ventricular ejection fraction (LVEF) presents unique prognostic challenges.
  • Surgical aortic valve replacement (AVR) is a standard treatment for symptomatic severe AS.

Purpose of the Study:

  • To evaluate the prognostic value of high-sensitive troponin T (hs-TnT) in patients with severe AS and preserved LVEF after AVR.
  • To identify predictors of major adverse cardiovascular events (MACE) in this patient cohort.
  • To explore the relationship between hs-TnT, global longitudinal strain (GLS), and MACE.

Main Methods:

  • Recruitment of 108 patients with severe symptomatic AS between April 2020 and February 2022.
  • Comprehensive echocardiography including assessment of LVEF, LV mass index, left atrium volume index, and GLS.
  • Measurement of hs-TnT levels and 6-month follow-up for MACE (cardiac death, heart failure re-admission, fatal arrhythmia).

Main Results:

  • Seventeen patients experienced MACE, including 8 cardiac deaths.
  • A statistically significant difference in MACE rates was observed between patients with normal and elevated hs-TnT levels (log-rank test, p=0.025).
  • Multivariate analysis identified hs-TnT (p<0.01) and GLS (p=0.022) as significant predictors of MACE, with a hs-TnT cutoff of 238.25 predicting MACE with 70% sensitivity and 81% specificity.

Conclusions:

  • Elevated hs-TnT is associated with a poor short-term prognosis following AVR in severe AS patients.
  • hs-TnT and GLS are significant predictors of future MACE in severe symptomatic AS patients with preserved LVEF undergoing AVR.
  • Elevated hs-TnT and impaired GLS may indicate the need for early intervention, even in asymptomatic severe AS.
Abstract